ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Should National Policymakers Augment Marginal Liver Transplants: A Population Game Approach

Nephrology, LUMC, Leiden, Netherlands
Clinical Epidemiology, LUMC, Leiden, Netherlands
Einthoven Laboratory for Experimental Vascular Research, LUMC, Leiden, Netherlands
Surgery, LUMC, Leiden, Netherlands

Meeting: 2013 American Transplant Congress

Abstract number: D1597

Purpose: Federal mandates have increased the availability of marginal livers for transplant despite worse outcomes. Yet the impact of augmenting marginal liver transplantation from the societal perspective is still unclear. We examined the waitlist dynamics and changes in patients' decisions using a population game approach. Method: We constructed a Stochastic Population Game model in which waitlist candidates respond to liver offers in various qualities to maximize their expected Quality Adjusted Life Year (QALY). We classified candidates into model for end-stage liver disease (MELD) quintiles (<11, 11-14, 15-20, 21-30, and >30). Also we put liver offers into 3 categories according to the Donor Risk Index (DRI), namely, low-risk (<1.2), medium-risk (between 1.2 and 1.8) and high-risk (>1.8). We demonstrated a system equilibrium in the model and examined the behavior of the equilibrium as organ offer rate changes in a wide range. Results: If high-risk organ offer rate is increased to above 160%, newly added organs would be totally discarded. If medium-risk organ offer rate is changed to between 60% and 100%, newly added organs would tempt some MELD 15-20 patients to step away from accepting high-risk organs. Conclusions: (1) MELD groups <11, 11-14 and >30 would not change their acceptance strategies, while MELD groups 21-30 and 15-20 would become more picky when more marginal organs are offered. (2) In general, the societal benefit increases with more marginal organs. However, it reaches a plateau in certain ranges, both for changes in high-risk and medium-risk organs. Attentions should be paid to these ranges when new allocation policy is made.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Should National Policymakers Augment Marginal Liver Transplants: A Population Game Approach [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/should-national-policymakers-augment-marginal-liver-transplants-a-population-game-approach/. Accessed May 17, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences